| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$267 |
Noosa Mining Investor Conference Presentation
|
23 Jul 2025 10:14AM |
$0.300 |
$0.690 |
risen by
130%
|
|
| International Graphite Limited (IG6) ORDINARY FULLY PAID |
Industrials |
$8 |
Pause in Trading
|
23 Jul 2025 10:09AM |
$0.072 |
$0.040 |
fallen by
44.44%
|
|
IG6 - Price-sensitive ASX Announcement
Full Release
Key Points
- International Graphite Limited requested an immediate pause in trading of its securities.
- The trading pause was requested pending an announcement about a material capital raising.
- The pause in trading was effective from 5 June 2024.
- It was expected the pause would last until 7 June 2024 or until the announcement was made.
- The request was made to the ASX in accordance with listing rules and procedures.
- No other information regarding the announcement was released at the time of the pause.
- The company’s securities would remain paused until further notice or the anticipated release.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Yowie Group Ltd (YOW) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Director Resignation 3Z - DS
|
23 Jul 2025 10:08AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
| Yowie Group Ltd (YOW) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Chair Resignation 3Z - DA
|
23 Jul 2025 10:07AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
| Yowie Group Ltd (YOW) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Director Resignation 3Z - AR
|
23 Jul 2025 10:07AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
| Lachlan Star Limited (LSA) ORDINARY FULLY PAID |
Materials |
$64 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Jul 2025 10:06AM |
$0.072 |
$0.175 |
risen by
143.06%
|
|
LSA - Price-sensitive ASX Announcement
Full Release
Key Points
- Lachlan Star continued exploration at the Koojan Cu-Ni-PGE Project in Western Australia.
- Soil sampling and assays confirmed a large copper-nickel anomaly at the project.
- No significant exploration occurred at the Princhester Magnesite Project during the quarter.
- The Appendix 5B cash flow report details exploration and administrative expenditures.
- The company’s cash position and operating expenses are outlined.
- The report confirms compliance with ASX listing rules and corporate governance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orbminco Limited (OB1) ORDINARY FULLY PAID |
Materials |
$8 |
Divestment of Mt Venn Project Completed
|
23 Jul 2025 10:02AM |
$0.001 |
$0.014 |
risen by
1,300%
|
|
| Sarama Resources Ltd (SRR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$13 |
OB1: Divestment of Mt Venn Project Completed
|
23 Jul 2025 10:02AM |
$0.034 |
$0.036 |
risen by
5.88%
|
|
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$324 |
NTA at 18.07.25 Pre-tax 141.86 Post-tax 136.57
|
23 Jul 2025 10:02AM |
$1.225 |
$1.255 |
risen by
2.45%
|
|
| Astute Metals NL (ASE) ORDINARY FULLY PAID |
Materials |
- |
Nevada Exploration and Strategy Update
|
23 Jul 2025 10:01AM |
$0.020 |
$0.017 |
fallen by
17.50%
|
|
ASE - Price-sensitive ASX Announcement
Full Release
Key Points
- Astute Metals NL is advancing its Nevada lithium projects, specifically the Columbine and Mustang assets.
- Recent efforts include fieldwork, permitting, and planning for future drill programs.
- The projects are situated in the Big Smoky Valley, a prospective area for lithium brine.
- Strategic rationale centers on the strong demand for US-sourced lithium and favorable market dynamics.
- Astute Metals NL aims to position itself as a significant contributor to the US lithium supply chain.
- The update reflects recent progress, milestones achieved, and outlines next steps in exploration.
- The company is responding to the growing strategic and economic importance of lithium in the US.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$596 |
Rise and Shine - Northern Honeypot Emerges
|
23 Jul 2025 10:00AM |
$0.595 |
$0.605 |
risen by
1.68%
|
|
SMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Santana Minerals Limited reported significant gold mineralization at the Northern Honeypot area within the RAS project.
- Recent drilling results have expanded the known mineralized zone, revealing high-grade gold intercepts.
- The company uses rigorous resource estimation methodologies and independent verification for its results.
- The Northern Honeypot is described as an emerging, high-potential area within the broader RAS deposit.
- Geological characteristics suggest strong continuity and scale of the mineralized system.
- Ongoing exploration is focused on further delineating resource boundaries and increasing confidence in the deposit.
- The RAS project is positioned as a key strategic asset for Santana Minerals Limited.
- Future work will include additional drilling, resource updates, and technical assessments to support project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$25 |
Release of shares from escrow
|
23 Jul 2025 9:57AM |
$0.150 |
$0.195 |
risen by
30%
|
|
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$324 |
Dividend/Distribution - PIA
|
23 Jul 2025 9:56AM |
$1.225 |
$1.255 |
risen by
2.45%
|
|
PIA - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement of a final dividend/distribution for Pengana International Equities Limited (PIA)
- Dividend amount specified as 4.5 cents per ordinary share, fully franked
- Ex-dividend date is 4 July 2024 and record date is 5 July 2024
- Payment date for the dividend is 26 July 2024
- Dividend Reinvestment Plan (DRP) is available for shareholders
- Shareholders can elect to participate or amend their DRP instructions by 5:00pm (Sydney time) on 8 July 2024
- Details provided for shareholders to update their personal or payment information
- Information on how to contact Share Registry for support or further guidance
- Announcement includes regulatory compliance statements and details for market communication
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$167 |
Noosa Mining Conference Investor Presentation
|
23 Jul 2025 9:55AM |
$0.120 |
$0.385 |
risen by
220.83%
|
|
| Askari Metals Limited (AS2) ORDINARY FULLY PAID |
Materials |
$7 |
Pause in Trading
|
23 Jul 2025 9:55AM |
$0.016 |
$0.010 |
fallen by
40.63%
|
|
AS2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Askari Metals Limited requested a trading pause.
- The pause is related to an upcoming announcement regarding AS2.
- Trading in AS2 securities is paused from the start of trading on 12 June 2024.
- The pause will end at the earlier of normal trading on 13 June 2024 or when the announcement is released.
- The pause was made under Listing Rule 17.1 of the ASX.
- Reason for the pause is the preparation of an announcement by Askari Metals Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nickel Industries Limited (NIC) ORDINARY FULLY PAID |
Materials |
$4,407 |
ENC Project Update
|
23 Jul 2025 9:55AM |
$0.770 |
$1.015 |
risen by
31.82%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$72 |
Capital Raising Presentation
|
23 Jul 2025 9:54AM |
$0.285 |
$0.140 |
fallen by
50.88%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited is undertaking a capital raising to fund the development of its lead drug, AMP945, an FAK inhibitor for cancer therapy.
- The capital raising is structured as a placement and rights issue for new shares.
- Funds raised will primarily be used for clinical trials, operational costs, and advancing AMP945 development, particularly in pancreatic cancer.
- Recent achievements include positive data from clinical studies and progression of AMP945 towards later-phase trials.
- The company outlines milestones and timelines for future clinical and regulatory activities.
- Additional indications for AMP945 and pipeline expansion are discussed.
- Details on share issuance, investor eligibility, offer terms, and schedule are provided.
- Key risks and forward-looking statements are disclosed to inform potential investors.
- Use of proceeds is projected to cover clinical trials, regulatory submissions, and working capital.
- Amplia’s management and board are highlighted, emphasizing their experience in biotech and drug development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$8 |
Fieldwork Underway at Evanstone & Yerilgee
|
23 Jul 2025 9:54AM |
$0.005 |
$0.056 |
risen by
1,144.44%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$72 |
Proposed issue of securities - ATX
|
23 Jul 2025 9:53AM |
$0.285 |
$0.140 |
fallen by
50.88%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$72 |
Proposed issue of securities - ATX
|
23 Jul 2025 9:53AM |
$0.285 |
$0.140 |
fallen by
50.88%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$72 |
Proposed issue of securities - ATX
|
23 Jul 2025 9:53AM |
$0.285 |
$0.140 |
fallen by
50.88%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$72 |
Amplia announces A$25m Placement and Launches A$2.5m SPP
|
23 Jul 2025 9:53AM |
$0.285 |
$0.140 |
fallen by
50.88%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited announced a A$25 million capital raising via a Placement to institutional and sophisticated investors.
- A Share Purchase Plan (SPP) has been launched to raise up to an additional A$2.5 million from eligible existing shareholders.
- The funds raised will be used to accelerate the clinical development of AMP945, Amplia’s lead drug candidate.
- Key focus areas include advancing AMP945 in combination with gemcitabine and Abraxane for pancreatic cancer treatment.
- Proceeds will also be used to support ongoing clinical trials, business development, and general working capital.
- The Placement was strongly supported by new and existing investors.
- The SPP will offer shares to eligible shareholders at the same price as the Placement.
- Amplia’s Board and management believe the additional funding will enable significant progress in clinical and corporate activities.
- The announcement outlines expected timelines for capital deployment and further milestones.
- The company thanks shareholders for their ongoing support and confidence in the Amplia business strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Codeifai Limited (CDE) ORDINARY FULLY PAID |
Industrials |
$7 |
Former NVIDIA A.I. Pioneer Appointed to Advisory Panel
|
23 Jul 2025 9:52AM |
$0.018 |
$0.007 |
fallen by
61.11%
|
|
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,653 |
June 2025 Quarterly Report
|
23 Jul 2025 9:49AM |
$5.300 |
$4.870 |
fallen by
8.11%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Phase 2 drilling at the Muckanippie Project significantly expanded the scale of the Rosewood Titanium Discovery.
- Heavy mineral (HM) mineralisation now extends over an area exceeding 20 square kilometres and remains open, particularly to the north.
- Phase 3 drill program completed, comprising 110 holes for 3,231 meters, with results expected in the next quarter.
- Two distinct, high-grade north-south trending mineralised zones identified at Rosewood East and West.
- Bulk sample metallurgical test work initiated to assess processing pathways and potential product specifications.
- Petratherm has earned a 51% interest in tenement EL 6715 and aims to increase this to 70%.
- Mr. Rob Sennitt appointed as Executive Director, contributing over 30 years of experience in the resources sector.
- The company held $8.4 million in cash at the end of the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,653 |
June 2025 Quarterly Report
|
23 Jul 2025 9:49AM |
$5.300 |
$4.870 |
fallen by
8.11%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of the Titanium Manufacturing Campus in Virginia.
- Recognition by the U.S. Government with an SBIR Phase III IDIQ contract.
- Strong financial position with $54.8 million cash on hand at end of June 2025.
- Private placement raising $46 million to accelerate production expansion.
- Focus on sustainable, low-cost titanium production.
- Strategic customer partnerships in automotive, aerospace, and defense sectors.
- U.S. Government funding commitments driving production scale-up.
- Development of the Titan Critical Minerals Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
